Fiona Tavner

486 total citations
8 papers, 398 citations indexed

About

Fiona Tavner is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Fiona Tavner has authored 8 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 2 papers in Cancer Research. Recurrent topics in Fiona Tavner's work include Cancer-related Molecular Pathways (4 papers), Ubiquitin and proteasome pathways (2 papers) and NF-κB Signaling Pathways (2 papers). Fiona Tavner is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Ubiquitin and proteasome pathways (2 papers) and NF-κB Signaling Pathways (2 papers). Fiona Tavner collaborates with scholars based in United Kingdom, Australia and United States. Fiona Tavner's co-authors include Roger Watson, Peter Karayiannis, Howard C. Thomas, R J Watson, Jon Frampton, V. Krishnapillai, Hong Wei, Andrew Hayward, Georgina E. Hollway and B. W. Holloway and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Oncogene.

In The Last Decade

Fiona Tavner

8 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fiona Tavner United Kingdom 8 152 132 112 85 70 8 398
Pénélope Legros France 8 260 1.7× 54 0.4× 58 0.5× 38 0.4× 47 0.7× 8 338
Rainer Löw Germany 10 204 1.3× 69 0.5× 86 0.8× 100 1.2× 35 0.5× 12 337
Magdalena Medrzycki United States 11 341 2.2× 53 0.4× 41 0.4× 28 0.3× 28 0.4× 17 425
Tovah E. Markowitz United States 10 255 1.7× 52 0.4× 43 0.4× 13 0.2× 79 1.1× 21 385
Saravana Kumar Kailasam Mani United States 9 314 2.1× 9 0.1× 126 1.1× 80 0.9× 63 0.9× 11 429
Kohtaro Fukushima Japan 6 291 1.9× 55 0.4× 76 0.7× 5 0.1× 33 0.5× 8 407
Cameron M. Soulette United States 5 306 2.0× 23 0.2× 77 0.7× 51 0.6× 10 0.1× 10 413
Eliane Lazar France 13 780 5.1× 84 0.6× 27 0.2× 8 0.1× 94 1.3× 18 871
Muhammad Ahmad Maqbool France 15 520 3.4× 34 0.3× 43 0.4× 17 0.2× 46 0.7× 20 662
Alana Sherker Canada 8 280 1.8× 9 0.1× 63 0.6× 63 0.7× 75 1.1× 10 381

Countries citing papers authored by Fiona Tavner

Since Specialization
Citations

This map shows the geographic impact of Fiona Tavner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona Tavner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona Tavner more than expected).

Fields of papers citing papers by Fiona Tavner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona Tavner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona Tavner. The network helps show where Fiona Tavner may publish in the future.

Co-authorship network of co-authors of Fiona Tavner

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona Tavner. A scholar is included among the top collaborators of Fiona Tavner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona Tavner. Fiona Tavner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Tavner, Fiona, et al.. (2008). Effect of basal core promoter and pre-core mutations on hepatitis B virus replication. Journal of General Virology. 89(4). 901–909. 97 indexed citations
2.
Tavner, Fiona, Jon Frampton, & R J Watson. (2006). Targeting an E2F site in the mouse genome prevents promoter silencing in quiescent and post-mitotic cells. Oncogene. 26(19). 2727–2735. 33 indexed citations
3.
Catchpole, Steven, et al.. (2002). A B-myb Promoter Corepressor Site Facilitatesin Vivo Occupation of the Adjacent E2F Site by p107·E2F and p130·E2F Complexes. Journal of Biological Chemistry. 277(41). 39015–39024. 19 indexed citations
4.
Bessa, Maria João, Manel Joaquin, Fiona Tavner, Mark K. Saville, & R J Watson. (2001). Regulation of the Cell Cycle by B-Myb. Blood Cells Molecules and Diseases. 27(2). 416–421. 22 indexed citations
5.
Facchinetti, Valeria, R. Lopa, F. Spreafico, et al.. (2000). Isolation and characterization of the human A-myb promoter: regulation by NF-Y and Sp1. Oncogene. 19(34). 3931–3940. 13 indexed citations
6.
Tavner, Fiona, Richard J. Simpson, Shigeki Tashiro, et al.. (1998). Molecular Cloning Reveals that the p160 Myb-Binding Protein Is a Novel, Predominantly Nucleolar Protein Which May Play a Role in Transactivation by Myb. Molecular and Cellular Biology. 18(2). 989–1002. 74 indexed citations
7.
Tavner, Fiona, Georgina E. Hollway, Mark Fegan, et al.. (1997). A novel method for development of species and strain-specific DNA probes and PCR primers for identifying Burkholderia solanacearum (formerly Pseudomonas solanacearum). Queensland's institutional digital repository (The University of Queensland). 5(1). 19–30. 129 indexed citations
8.
Gonda, Thomas J., et al.. (1996). The c-Myb Negative Regulatory Domain. Current topics in microbiology and immunology. 211. 99–109. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026